Article Information
History
- May 14, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Celine Lewis1,
- Felicity Boardman2,
- James Buchanan3,
- Sigrún Clark4,
- Katie Gilchrist4,
- Pia Hardelid1,
- Amy Hunter5,
- Jennifer Jones5,6,
- Kerry Leeson-Beevers7,
- Bethany Stafford-Smith8,9,
- Cecilia Vindrola-Padros4,
- Martin Vu3,
- Wing Han Wu8,9,
- Ania Zylbersztejn1 and
- Melissa Hill8,9,*
- 1Population, Policy and Practice, UCL Great Ormond Street Institute of Child Health, London, UK
- 2Warwick Medical School, Warwick University, Coventry, UK
- 3Health Economics and Policy Research Unit (HEPRU), Queen Mary University of London, London, UK
- 4Rapid Research Evaluation and Appraisal Lab (RREAL), University College London, London, UK
- 5Genetic Alliance UK, London, UK
- 6Department of Population Health Sciences, University of Leicester, Leicester, UK
- 7Alström Syndrome UK and Breaking Down Barriers, Torquay, UK
- 8NHS North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
- 9Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK
- ↵*Corresponding Author Melissa Hill NHS North Thames Genomic Laboratory Hub Level 5, Barclay House, 37 Queen Square, London WC1N 3BH Email: melissa.hill{at}ucl.ac.uk
Posted May 14, 2024.
Exploring the feasibility, acceptability and impact of genomic newborn screening for rare diseases in England: A study protocol for the Generation Study - Process and Impact Evaluation
